Literature DB >> 22832237

Prenatal immune stress in rats dampens fever during adulthood.

Abdeslam Mouihate1, Mouihate Abdeslam.   

Abstract

Fever is a major component of the host's defense against infection. Inadequate febrile response can predispose an individual to the deleterious effects of infection. Neonatal exposure to infectious agents such as bacterial lipopolysaccharide (LPS) permanently dampens the adult febrile response. Whether prenatal immune challenge alters febrile response during adulthood is still not known. In the present study, LPS (100 µg/kg, i.p.) or pyrogen-free saline was administered to pregnant rats on either gestation day (GD) 12, 15 or 19 and the febrile response of their respective adult offspring was monitored. During adulthood (>70 days old), the rats born to LPS-injected dams on GD15 displayed a significantly attenuated febrile response to LPS (50 µg/kg, i.p.) compared to their control counterparts born to dams given saline on GD15. Immune challenge during either early (GD12) or late (GD19) pregnancy did not have a significant impact on fever in the adult offspring. Immune challenge on GD15, but not on GD12 or 19, heightened the plasma corticosterone response to a subsequent LPS injection to the adult offspring but did not have a significant effect on their basal plasma corticosterone levels. Finally, LPS-induced COX-2 in the fever-controlling regions of the hypothalamus was significantly reduced in the adult rats born to dams given LPS on GD15 compared to their counterparts born to dams given saline on GD15. Such COX-2 reduction was not observed in the adult offspring born to dams given LPS on either GD12 or 19. Taken together, these data suggest that a single immune challenge during a critical window of pregnancy alters the neuroimmune response in adult offspring.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832237     DOI: 10.1159/000339852

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  8 in total

1.  Impact of prenatal immune challenge on the demyelination injury during adulthood.

Authors:  Abdeslam Mouihate; Hessah Al-Hashash; Sarah Rakhshani-Moghadam; Samah Kalakh
Journal:  CNS Neurosci Ther       Date:  2017-07-17       Impact factor: 5.243

2.  Toll-like receptor 4-mediated immune stress in pregnant rats activates STAT3 in the fetal brain: role of interleukin-6.

Authors:  Abdeslam Mouihate; Heba Mehdawi
Journal:  Pediatr Res       Date:  2015-05-04       Impact factor: 3.756

3.  Prenatal Inflammation Dampens Neurogenesis and Enhances Serotonin Transporter Expression in the Hippocampus of Adult Female Rats.

Authors:  Abdeslam Mouihate; Samah Kalakh; Rawan AlMutairi; Abdelrahman Alashqar
Journal:  Med Princ Pract       Date:  2019-03-19       Impact factor: 1.927

4.  Neonatal systemic exposure to lipopolysaccharide enhances susceptibility of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life.

Authors:  Zhengwei Cai; Lir-Wan Fan; Asuka Kaizaki; Lu-Tai Tien; Tangeng Ma; Yi Pang; Shuying Lin; Rick C S Lin; Kimberly L Simpson
Journal:  Dev Neurosci       Date:  2013-02-22       Impact factor: 2.984

Review 5.  Developmental origin and sex-specific risk for infections and immune diseases later in life.

Authors:  Dimitra E Zazara; Petra Clara Arck
Journal:  Semin Immunopathol       Date:  2018-10-08       Impact factor: 9.623

6.  Anticancer activity of Pupalia lappacea on chronic myeloid leukemia K562 cells.

Authors:  Alvala Ravi; Mallika Alvala; Venkatesh Sama; Arunasree M Kalle; Vamshi K Irlapati; B Madhava Reddy
Journal:  Daru       Date:  2012-12-05       Impact factor: 3.117

7.  Prenatal Activation of Toll-Like Receptor-4 Dampens Adult Hippocampal Neurogenesis in An IL-6 Dependent Manner.

Authors:  Abdeslam Mouihate
Journal:  Front Cell Neurosci       Date:  2016-06-30       Impact factor: 5.505

Review 8.  Long-lasting impact of early life immune stress on neuroimmune functions.

Authors:  Abdeslam Mouihate
Journal:  Med Princ Pract       Date:  2013-08-13       Impact factor: 1.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.